- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02085681
Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases (DRTM)
Effectiveness of Tele-medicine in Identifying Diabetic Retinopathy Cases Attending Diabetologists' Clinics Compared to the Conventional Referral System
The aim of this study is to compare the effectiveness of identifying diabetic retinopathy using tele-medicine based Digital Retinal Imaging in Diabetes Clinics with that of the conventional referral system.
Hypothesis: Tele-medicine based digital retinal imaging involving a diabetes centre will identify proportionately more diabetic patients with DR and lead to higher acceptance rate with subsequent ophthalmic referral and management
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tamil Nadu
-
Madurai, Tamil Nadu, India, 625020
- Aravind Eye Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diabetic patients (as per ICD-9 code 250) in the age group of ≥50 years
Exclusion Criteria:
- Patients <50 years of age
- Already enrolled as study patients at the diabetes centre
- Patients screened for DR in free camps organized by the diabetes centre
- Diabetic patients who underwent retinal examination in the previous year prior to this intervention
- Patients with disability (physical or mental) who have difficulty in travelling to the eye hospital
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Tele-medicine
Tele-medicine aided retinal imaging and referral to eye hospital
|
Patients at the diabetes clinics will be subjected to non-mydriatic retinal imaging and the images will be transferred to the eye hospital via internet using a specified software - Aravind Diabetic Retinopathy Evaluation Software (ADRES) that enables a retinal specialist to read and grad the image and send the feedback immediately to the diabetes clinic.
Based on the presence or absence of DR the patients will be referred to the eye hospital for detailed retinal examination.
Other Names:
|
Other: Conventional Referral
Patients will be counselled on the importance of eye examination and will be referred to the eye hospital in the conventional manner.
|
All eligible patients in the conventional arm will be counselled on the importance of eye screening and will be referred to the eye hospital
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of patients with confirmed Diabetic Retinopathy (DR) diagnosed at the eye hospital
Time Frame: 6 months
|
Out of the patients referred from the diabetes clinics to the eye hospital, the number of patients with confirmed DR will be measured.
This proportion will be compared between the two arms.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The severity of diabetic retinopathy (DR)
Time Frame: 6 months
|
Among patients confirmed with DR, the severity of the disease will be measured using standard classification (Diabetic Retinopathy Disease Severity Scale) approved by the American Academy of Ophthalmology
|
6 months
|
The acceptance rate for referral in each arm
Time Frame: 6 months
|
Out of the patients referred from the diabetes clinic, the number of patients actually reported to the eye hospital will be measured.
|
6 months
|
Proportion of patients eligible for referral who had DR and who did not attend
Time Frame: 6 months
|
Patients who are referred by not attended to the eye hospital will be followed up and examined to find out what proportion of them actually as DR
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Barriers to compliance
Time Frame: 6 months
|
Patients will be interviewed to identify the barriers to compliance following the referral
|
6 months
|
Drivers of acceptance
Time Frame: 6 months
|
Patients will be interviewed to identify the factors that encouraged them to visit the eye hospital following referral
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Sanil Joseph, MHA, MSc, Lions Aravind Institute of Community Ophthalmology, Aravind Eye Hospital, Madurai, India
- Study Chair: Ramasamy Kim, DO, DNB, Aravind Eye Hospital, Madruai, India
- Study Chair: Thulasiraj Ravilla, MBA, Lions Aravind Institute of Community Ophthalmology, Aravind Eye Hospital, Madurai
- Study Chair: Astrid Fletcher, MSc, PhD, London School of Hygiene and Tropical Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WT097685MA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetic Retinopathy
-
Retina Institute of HawaiiUnknownDiabetic Macular Edema | Proliferative Diabetic Retinopathy | Severe Nonproliferative Diabetic Retinopathy | Mild Nonproliferative Diabetic Retinopathy | Moderate Nonproliferative Diabetic RetinopathyUnited States
-
University of CataniaUnknownProliferative Diabetic Retinopathy | Non Proliferative Diabetic RetinopathyItaly
-
Asociación para Evitar la Ceguera en MéxicoCompletedProliferative Diabetic Retinopathy | Severe Nonproliferative | Active Photocoagulated Diabetic RetinopathyMexico
-
Asociación para Evitar la Ceguera en MéxicoUnknownProliferative Diabetic Retinopathy | Non Proliferative Diabetic RetinopathyMexico
-
Asociación para Evitar la Ceguera en MéxicoUnknownNon Proliferative Diabetic Retinopathy. | Proliferative Diabetic Retinopathy.Mexico
-
Valo Health, Inc.RecruitingProliferative Diabetic Retinopathy | Non-proliferative Diabetic RetinopathyUnited States
-
AEYE Health IncA. Stein Regulatory Affairs Consulting Ltd.RecruitingDiabetic Mellitus | Diabetic Retinopathy, DRUnited States
-
Ocuphire Pharma, Inc.CompletedDiabetic Retinopathy | Diabetic Macular Edema | NPDR - Non Proliferative Diabetic Retinopathy | PDR - Proliferative Diabetic RetinopathyUnited States
-
King Khaled Eye Specialist HospitalCompletedDiabetic Macular Edema | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic RetinopathySaudi Arabia
-
Retina Macula InstituteAllerganCompletedDiabetic Macular Edema | Proliferative Diabetic Retinopathy | Non-proliferative Diabetic RetinopathyUnited States
Clinical Trials on Tele-medicine
-
Professor Adrian CovicMedical Sciences Academy - Romania; Victor Babes Clinical Hospital of Infectious...UnknownCoronary Artery Disease | Hypertension | Covid-19 | Angina Pectoris | Acute Coronary Syndrome | Heart Failure, Systolic | Depression, Anxiety | Coronary Syndrome | Stent Restenosis | Angioplasty | Isolation, SocialRomania
-
Shalvata Mental Health CenterSHL Telemedicine Ltd.UnknownSchizophrenia | Schizoaffective DisorderIsrael
-
University Hospital, MontpellierEuropean Union; Occitanie RegionTerminatedRheumatoid ArthritisFrance
-
Dartmouth-Hitchcock Medical CenterUniversity of Texas at AustinCompleted
-
Baylor College of MedicineBioSensicsRecruitingCognitive Impairment | Dementia | Mild Cognitive Impairment | Memory LossUnited States
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH)RecruitingAutism Spectrum DisorderUnited States
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Clalit Health ServicesTerminated
-
Centro Universitário Augusto MottaRecruiting
-
The University of Texas Medical Branch, GalvestonRecruiting